Purchases and Sales Made in Q3 2023 in Astellas Pharma Inc Unsponsore (ALPMY)
This table provides information about the institutional ownership of Astellas Pharma Inc Unsponsore (ALPMY) during Q3 2023. The information is specifically focused on institutions that hold shares of Astellas Pharma Inc Unsponsore.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Mai Capital Management
|
BUY
|
- |
7.87K+ 70.1% |
$109K - $122K
|
19.1K
$189K
|
|
Nov 13, 2023
Q3 2023
|
Russell Investments Group, Ltd.
|
BUY
|
- |
392+ 100.26% |
$5.43K - $6.1K
|
783
$7.74K
|
|
Nov 13, 2023
Q3 2023
|
Operose Advisors LLC
Milwaukee, WI |
BUY
|
- |
90New |
$1.25K - $1.4K
|
90
$889
|
|
Nov 09, 2023
Q3 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
15+ 0.04% |
$208 - $233
|
34.8K
$343K
|
|
Nov 13, 2023
Q3 2023
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
SELL
|
- |
-6- 3.49% |
$83.1 - $93.3
|
166
$1.64K
|
|
Oct 23, 2023
Q3 2023
|
Svb Wealth LLC
Boston, MA |
SELL
|
- |
-1.61K- 13.3% |
$22.3K - $25K
|
10.5K
$103K
|
|
Nov 13, 2023
Q3 2023
|
Renaissance Group LLC
Covington, KY |
SELL
|
- |
-27.2K- 6.5% |
$377K - $424K
|
392K
$3.87M
|
|
Aug 06, 2024
Q3 2023
|
Hantz Financial Services, Inc.
|
SELL
|
- |
-116K- 73.67% |
$1.61M - $1.81M
|
41.6K
$411K
|